Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Washer 

Boston Scientific diskutieren

Boston Scientific

WKN: 884113 / Symbol: BSX / Name: Boston Scient / Aktie / Ausrüstung & Versorgung / Large Cap /

79,00 €
0,77 %

Einschätzung Buy
Rendite (%) -11,24 %
Kursziel 110,18
Veränderung
Endet am 25.04.26

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Barclays PLC from $118.00 to $125.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat

Boston Scientific Co. (NYSE: BSX) was upgraded by analysts at Erste Group Bank AG to a "strong-buy" rating.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -16,67 %
Kursziel 111,59
Veränderung
Endet am 16.05.26

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Morgan Stanley from $120.00 to $125.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -15,05 %
Kursziel 110,24
Veränderung
Endet am 22.05.26

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Citigroup Inc. from $119.00 to $125.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -15,24 %
Kursziel 101,61
Veränderung
Endet am 28.05.26

Boston Scientific Co. (NYSE: BSX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $115.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -8,35 %
Kursziel 102,33
Veränderung
Endet am 16.06.26

Boston Scientific Co. (NYSE: BSX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $118.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Boston Scientific Co. (NYSE: BSX) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -10,63 %
Kursziel 104,12
Veränderung
Endet am 21.07.26

Boston Scientific Corporation (NYSE: BSX) was given a new $121.00 price target on by analysts at Raymond James Financial, Inc.. They now have a "strong-buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -14,69 %
Kursziel 112,96
Veränderung
Endet am 24.07.26

Boston Scientific Corporation (NYSE: BSX) had its price target raised by analysts at Barclays PLC from $125.00 to $133.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -14,69 %
Kursziel 104,46
Veränderung
Endet am 24.07.26

Boston Scientific Corporation (NYSE: BSX) had its price target raised by analysts at Robert W. Baird from $117.00 to $123.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -14,69 %
Kursziel 106,16
Veränderung
Endet am 24.07.26

Boston Scientific Corporation (NYSE: BSX) had its price target raised by analysts at Truist Financial Corporation from $120.00 to $125.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -12,42 %
Kursziel 105,31
Veränderung
Endet am 24.07.26

Boston Scientific Corporation (NYSE: BSX) had its price target raised by analysts at Wells Fargo & Company from $118.00 to $124.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -12,61 %
Kursziel 105,31
Veränderung
Endet am 24.07.26

Boston Scientific Corporation (NYSE: BSX) had its price target raised by analysts at Raymond James Financial, Inc. from $121.00 to $124.00. They now have a "strong-buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -12,61 %
Kursziel 114,66
Veränderung
Endet am 24.07.26

Boston Scientific Corporation (NYSE: BSX) had its price target raised by analysts at UBS Group AG from $130.00 to $135.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Boston Scientific Corporation (NYSE: BSX) had its "outperform" rating re-affirmed by analysts at Royal Bank Of Canada.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -13,94 %
Kursziel 106,75
Veränderung
Endet am 08.09.26

Boston Scientific (NYSE:BSX) was upgraded by analysts at Oppenheimer Holdings, Inc. from a "market perform" rating to an "outperform" rating. They now have a $125.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,83 %
Kursziel 103,43
Veränderung
Endet am 11.09.26

Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $121.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -6,18 %
Kursziel 102,74
Veränderung
Endet am 19.09.26

Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $121.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,66 %
Kursziel 107,47
Veränderung
Endet am 23.09.26

Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $127.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) -5,05 %
Kursziel 106,64
Veränderung
Endet am 29.09.26

Boston Scientific (NYSE:BSX) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $125.00 price target on the stock.
Ratings data for BSX provided by MarketBeat